Fusion proteins, DNA molecules, vectors, and host cells useful for measuring protease activity
AssigneeVertex Pharmaceuticals Incorporated
InventorsUrsula Germann, Thomas Hoock, Ann Kwong
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel fusion proteins, DNA molecules encoding the same, vectors comprising the DNA molecules, and host cells containing the vectors for use in measuring protease activity using a novel transcriptional assay. This invention also relates to a method for determining the inhibitory activity of a compound against a protease and to a method for comparing the activity of two proteases which recognize the same cleavage site. Kits for assaying protease activity comprising DNA molecules encoding the fusion protein substrates of this invention are also contemplated.
Claims13
A method for determining the inhibitory activity of a compound against a protease comprising the steps of:
- (A) in the absence of said compound, culturing in a first culture a host cell that expresses the protease to be assayed and a fusion protein, wherein said host cell comprises:
- (1) a first DNA molecule encoding the fusion protein or a vector comprising said first DNA molecule, wherein said fusion protein comprises:
- (a) a protease cleavage site
- (b) a ligand binding domain;
- and
- (c) a DNA binding domain;
- wherein the fusion protein also comprises an expression modulator domain, wherein said expression modulator domain regulates the transcription of a reporter gene;
- and wherein said protease cleavage site of said fusion protein is a target for cleavage by said protease;
- and
- (2) a second DNA molecule comprising:
- (a) a ligand-responsive element ("LRE"), which binds to said DNA binding domain of said fusion protein, wherein said binding is modulated by the presence of a ligand and is optionally modulated by the presence of a protein binding partner of said fusion protein;
- (b) a promoter which is modulated by said expression modulating domain of said fusion protein;
- and
- (c) a reporter gene, the expression of which is controlled by said promoter;
- (B) culturing in a second culture the host cell as used in step (A) in the presence of said compound under conditions which cause expression of said fusion protein;
- (C) adding to said first and to said second host cell cultures a ligand, wherein said ligand is required for said fusion protein to (i) bind to said LRE or to bind to a protein binding partner;
- and (ii) modulate the transcription of said reporter gene;
- and
- (D) comparing the amount of gene product produced from said reporter gene in said first host cell culture and said second host cell culture.
Dependencies are inferred from the claim text.